Efficacy and safety of GLP-1 receptor agonists versus SGLT-2 inhibitors in overweight/obese patients with or without diabetes mellitus: a systematic review and network meta-analysis

OBJECTIVE: To compare the efficacy and safety between and within glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter 2 inhibitors (SGLT-2is) in overweight or obese adults with or without diabetes mellitus. METHODS: PubMed, ISI Web of Science, Embase and Cochrane Cen...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Hong, Lin, Yu-Hao, Dai, Li-Zhen, Lin, Chen-Shi, Huang, Yanling, Liu, Shu-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Diabetes and Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008474/
https://www.ncbi.nlm.nih.gov/pubmed/36882248
http://dx.doi.org/10.1136/bmjopen-2022-061807

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008474/
https://www.ncbi.nlm.nih.gov/pubmed/36882248
http://dx.doi.org/10.1136/bmjopen-2022-061807

Ejemplares similares